Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 3, 2013, Pages 218-225

  Gao, Feng ^a   Sun, Zhijun ^a   Sun, Xin ^a   Zhang, Yonghua ^a   Wang, Hong ^a   Zhong, Biao ^a   Luo, Jie ^a   Zhao, Xiaoliang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Breast cancer; Epithelial mesenchymal transition; Invasion; Metastasis; Taxotere; Ulinastatin

Indexed keywords

DOCETAXEL; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; TRANSFORMING GROWTH FACTOR BETA1; ULINASTATIN; VASCULOTROPIN C;

AGED; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INVASION; CANCER SURGERY; CONTROLLED STUDY; DRUG POTENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MASTECTOMY; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

AGED; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DRUG SYNERGISM; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; TAXOIDS; TRYPSIN INHIBITORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84876116281     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2011.1122     Document Type: Article

References (25)

1. Hiatt RA, Haslam SZ, Qsuch J, et al. The breast cancer and the environment research centers: Transdisciplinary research on the role of the environment in breast cancer etiology. Environ Health Perspect 2009;117:1814
2. Kalluri R,Weinberg RA. The basics of epithelial-mesenchymal transition. Clin Invest 2009;119:1420
3. Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. Cell Physiol 2007;213:374
4. Sun ZJ, Yu T, Chen JS, et al. Effects of ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXC chemokine receptor 4 and matrix metalloproteinase-9 in cancers. J Int Med Res 2010; 38:967
5. Chen JS, Sun ZJ, Yu T. Effects of ulinastatin and cyclophosphamide on proliferation and invasion of breast cancer cells and expression of matrix metalloproteinase-9. Chin J Biol 2009;22:865
6. Jin ZJ. [Addition in drug combination (author's transl)]. Zhongguo Yao Li Xue Bao 1980;1:70
7. Malkas LH, Herbert BS, Abdel-Azix W, et al. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. PNAS 2006;103:19472
8. Bourguignon LY, Singleton PA, Diedrich F, et al. CD44 interaction with Na + -H + exchanger creates acidic microenvironments leading to hyaluronidase 2 and cathepsin-B activation and breast tumor cell invasion. J Biol Chem 2004;279:26991
9. Mine S, Fujisaki T, Kawahara C, et al. Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up regulation of CD44. Exp Cell Res 2003;288:189
10. Schoppmann SF, Fenzl A, Nagy K, et al. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: Impact on lymphangiogenesis and survival. Surgery 2006;139:839
11. Chilov D, Kukk E, Taira S, et al. Genomic organization of human and mouse genes for vascular endothelial growth factor. J Biol Chem 1997;272:25176
12. Wu YJ, Ling Q, Zhou XH, et al. Urinary trypsin inhibitor attenuates hepatic ischemia-reperfusion injury by reducing nuclear factor-kappa B activation. J Hepatobiliary Pancreat Dis Int 2009;8:53
13. Xie XB, Long J, Yang F, et al. Role of short haipin RNA targeting vascular endothelial growth factor-C on biological characteristics of human breast cancer cell MCF-7J. Zhonghua Bing Li Xue Za Zhi 2009;38:472
14. Shi X, Chen G, Xing H, et al. VEGF-C, VEGFR-3, and COX-2 enhances growth and metastasis of human cervical carcinoma cell lines in vitro. J Oncol Rep 2007;18:241
15. El YI, Boilly-Marer Y. Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231. Anticancer Res 1995; 15:783
16. Giatromanolaki A, Sivridis E, Brekken R, et al. The angiogenic ''vascular endothelial growth factor/flk-1(KDR) receptor'' pathway in patients with endometrial carcinoma: Prognostic and therapeutic implications. Cancer 2001;92:2569
17. Melnikova VO, Balasubramanian K, Villares GJ, et al. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 2009;284:28845
18. Aponte M, Jiang W, Lakkis M, et al. Activation of PAFreceptor and pleiotropic effects on tyrosine phospho-EGFR/ Src/FAK/paxillin in ovarian cancer. Cancer Res 2008;68:5839
19. Melnikova VO, Mourad-Zeidan AA, Lev DC, et al. Plateletactivating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element binding protein and contributes to melanoma metastasis. J Biol Chem 2006;281:2911
20. de Oliveira SI, Andrade LN, Onuchic AC, et al. Plateletactivating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer 2010;10:200
21. Caseio S, Ferla R, D Andrea A, et al. Expression of angiogenic regulators, VEGF and leptin, is regulated by the EGF/ PI3K/STAT3 pathway in colorectal cancer cells. J Cell Physiol 2009;221:189
22. Galizia G, Lieto E, Ferraraccio F, et al. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery. Ann Surg Oncol 2006;13:823
23. Perrotte P, Matsumoto T, Inome K, et al. Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice. Clin Cancer Res 1999;5:257
24. Wendt MK, Smith JA, Schiemann WP, et al. P130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity. J Biol Chem 2009;284:34145
25. Wendt MK, Smith JA, Schiemann WP. Transforming growth factor-b-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 2010;29:6485